Results 101 to 110 of about 1,578,947 (161)

Organ preservation with total neoadjuvant therapy in early-stage rectal cancer: A statewide analysis. [PDF]

Colorectal Dis
Bunjo Z, Fitzsimmons T, Nguyen TM, Penniment M, Selva-Nayagam S, Tonkin D, Sia TC, Murphy E, Thomas M, Sammour T.   +9 more
europepmc   +1 more source

High therapeutic efficacy of triplet therapy in unresectable or metastatic colorectal cancer and its optimal application strategies. [PDF]

Int J Clin Oncol
Sakuyama H, Okuyama H, Tahara Y, Tsukamoto S, Kita I, Nomura K, Murakami A, Okita Y, Satake H, Kato T, Tsuji A.   +10 more
europepmc   +1 more source

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial. [PDF]

ESMO Open
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Macdonald T, Ryder D, Ramage J, Davies LM, Bridgewater JA, Valle JW, Advanced Biliary Cancer (ABC) Working Group.   +21 more
europepmc   +1 more source

Recurrent Cytokine Release Syndrome in Metastatic Gastric Cancer on Nivolumab-FOLFOX: A Case Report and Mechanistic Review. [PDF]

J Gastrointest Cancer
Islam J, Rashid Z, Munster AB, Hughes P, Badzek S, Huda I.   +5 more
europepmc   +1 more source

In Vitro Anti-Glioblastoma Activity of a Novel Pt(IV)-Ganoderic Acid A Conjugate. [PDF]

Int J Mol Sci
Gaiaschi L, De Luca F, Serapian SA, Lugli E, Maraschi F, Bini A, Merli D, Bottone MG.   +7 more
europepmc   +1 more source

Short-Chain and Long-Chain Fatty Acid-Containing Platinum-Acridine Anticancer Prodrugs: Exploiting Alternative Mechanisms of Cellular Internalization. [PDF]

J Med Chem
Halatek DJ, Bo SA, Feder SM, Wolf L, Coffin DJ, Sapp LA, Marrs GS, Fontoura BM, Jones BT, Bierbach U.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Organoplatinum compounds VII

Journal of Organometallic Chemistry, 1998
Abstract The structural chemistry of organoplatinum clusters [Me3PtX]4 (X=halide) has been completed with the synthesis and X-ray investigation of [Me3PtF]4 (1) and its structural comparison to the well-known hydroxide [Me3PtOH]4 (2), all members of the ‘organoplatinum cubane’ family.
H Donath, E.V Avtomonov, I Sarraje, K.-H von Dahlen, M El-Essawi, J Lorberth, B.-S Seo   +6 more
exaly   +2 more sources

Electron impact ionisation cross section for organoplatinum compounds

Molecular Physics, 2016
ABSTRACTThis article reports electron impact ionisation cross sections for platinum-based drugs viz., cisplatin (H6N2Cl2Pt), carboplatin (C6H12N2O4Pt), oxaliplatin (C8H14N2O4Pt), nedaplatin (C2H8N2O3Pt) and satraplatin (C10H22ClN2O4Pt) complexes used in the cancer chemotherapy.
Dibyendu Mahato, Shabbir Ahmad, Bobby Antony   +2 more
exaly   +2 more sources

Synthesis and Reactions of Organoplatinum Compounds of C60, C60Ptn

Chemistry Letters, 1994
Abstract The organoplatinum compound of C60, C60Ptn (n = 1–2), was prepared either by the reaction of C60 with Pt(dba)2 or by the thermal disproportionation of C60Ptn (n = ca. 1). The C60Ptn obtained catalyzed the hydrogenation of diphenylacetylene regardless of the platinum content. Cleavage of carbon-platinum bonds of C60Ptn (n = ca. 1)
Hideo Nagashima, Kenji Itoh
exaly   +2 more sources